|
Roy
S. Weiner, M.D. - Dr. Roy Weiner is the Schlieder Professor
of Medical Oncology and Director of the Tulane Cancer Center
and also serves as Director of the
CRCA Program. Dr. Weiner trained at the NCI, at the Institut
for Cancerologie et d'Immunogenetique in Villejuif under Prof.
George Mathe, and at Harvard. His laboratory research focused
on stem cell physiology and cryobiology of lymphoid populations.
He has enormous experience in designing and executing small
translational clinical trials, large prospective randomized
therapeutic trials, and the analysis of large registry databases.
He has directed cancer activities as PI of the NCI-funded
Cancer Center Planning Grant at the University of Florida.
During his tenure as Program Director at the University of
Florida, he was responsible for the training of 29 medical
oncologists, 14 of whom currently hold full-time academic
positions on the faculty of major medical schools. He was
also the laboratory preceptor for eight trainees who are now
full-time academicians and have independent research programs.
He has served the NIH as Chairman of the Clinical Sciences
Study Section (NRSA), and was a member of the Clinical Program
Project Study Section and the CCIRC.
L. Lee Hamm, M.D. serves as Associate Project Director for the CRCA Program.
Dr. Hamm is Professor of Medicine, Chief of the Section of Nephrology and Hypertension, Vice-Chair of the Department of Medicine, and Director of the recently established Tulane Hypertension and Renal Center of Excellence. He is an established, productive scientist who is involved in both basic investigation and clinical studies. He has been funded by the NIH for many years, and also by the VA and the American Heart Association. He has received many awards for his work including a Merit Award from the NIH, an Established Investigator Award from the American Heart Association, and membership in the American Society of Clinical Investigation. He currently belongs to the Nephrology Board of the American Board of Internal Medicine. As listed elsewhere, he has published widely and has trained many academic physicians, several with ongoing NIH support.
Larry Webber,
Ph.D. - Dr. Webber is Professor and Chair of the Department
of Biostatistics, TSPHTM. He has over 25 years of experience
in medical and epidemiological research. He received a doctorate
in Biometry from Yale University. Since 1987 he has been the
Principal Investigator for the Louisiana site for the Child
and Adolescent Trial for Cardiovascular Health, (CATCH) an
NIH-sponsored multi-site clinical trial to promote healthy
behaviors in elementary school children. He is a member of
the CATCH National Steering Committee and chairs the CATCH
Measurement Committee. Dr. Webber is the principal author
or co-author of over 160 publications in scientific journals,
2 books, and several book chapters. In 1999, he was appointed
as a permanent member of the Epidemiology and Disease Control-1
(EDC-1) Study Section. The total funding to Dr. Webber is
over $3.2 million.
Jiang He, M.D., Ph.D. will serve as a member of the Core Faculty and “host” for the CRCA Program’s MPH in Clinical Research. Dr. He is Professor of Epidemiology and Medicine and Chair of the Department of Epidemiology. Dr. He has extensive experience in NIH-sponsored clinical and population-based research. Currently, his NIH research funding is approximately 3 million dollars per year. He also has extensive experience in training physician scientists. He has trained 7 MD/PhD or MD/MPH researchers and currently advises 8 physician trainees.
John J. Lefante,
Jr., Ph.D. - Dr. Lefante is an Associate Professor
of Biostatistics in the Department of Biostatistics, TSPHTM.
He received his Ph.D. in Statistics from the University of
Alabama. Dr. Lefante has 19 years of experience teaching a
variety of applied statistics courses, including Introductory
Biostatistics, Intermediate Biostatistics, Regression Analyses,
and Sampling. He has twice been the recipient of the TSPHTM
Excellence in Teaching Award, and a recipient of the Department
of Health Systems Management Masters of Medical Management
Excellence in Teaching Award. Dr. Lefante's research interests
focus on statistical analyses and environmental and occupational
health effects data, including statistical methodology for
study design, sample size and power calculations, especially
for longitudinal data.
Marie Krousel-Wood,
M.D., M.S.P.H. - Dr. Krousel-Wood received her M.D.
degree from Louisiana State University Medical School in New
Orleans and an MSPH degree from the TSPHTM. She is the Assistant
Dean for Graduate Medical Education at the TSPHTM and is the
Director of the Preventive Medicine Residency Program. She
also co-directs the combined Preventive Medicine/Internal
Medicine Program at Tulane University Medical Center. The
combined Preventive Medicine/Internal Medicine Program is
a unique program designed to train residents for careers in
academic, administrative and/or clinical preventive medicine/public
health. The Preventive Medicine Residency Program is a 2-year
accredited program designed to lead to certification by the
American Board of Preventive Medicine. She is funded by several
grants in clinical research including being the PI of a grant
from the Agency for Health Care Quality and Research (studies
in hypertension) and PI for a Center for Disease Control and
Prevention grant (medical genetics test reporting). Dr. Krousel-Wood
also directs the combined MD/MPH Program at Tulane which offers
a four-year program resulting in the awarding of both degrees.
Juan Lertora,
M.D., Ph.D. - Dr. Lertora received his M.D. degree
from the National University of the Northeast, Faculty of
Medicine, Corrientes, Argentina and a Ph.D. in Pharmacology
at Tulane University. He is a Professor of Medicine and Chief,
Section of Clinical Pharmacology, Departments of Medicine
and Pharmacology, Tulane University School of Medicine. He
is the Principal Investigator of the NIH-sponsored Tulane-LSU
Adult AIDS Clinical Trials Unit and Program Director of the
NIH-sponsored Tulane/LSU GCRC. Dr. Lertora has trained several
fellows in Clinical Pharmacology and also provided mentorship
for fellows in infectious diseases conducting special projects.
Total funding to Dr. Lertora is approximately $3 million.
William C. Steinmann,
M.D., M.Sc. - Dr. Steinmann received his M.D. degree
from the University of Missouri School of Medicine and a M.Sc.
from the London School of Hygiene and Tropical Medicine, London.
Prior to coming to Tulane he was a Robert Wood Johnson Clinical
Scholar at the University of Pennsylvania School of Medicine.
He is currently Professor of Medicine, Tulane University School
of Medicine and holds the Jack R. Aron Chair in Primary Care.
He is the Director of the Tulane Center for Clinical Effectiveness
and Prevention.
Barbara Beckman,
Ph.D. - Dr. Beckman received her Ph.D. from Johns Hopkins
School of Medicine in 1978. She is currently Professor of
Pharmacology, Tulane University School of Medicine. Her research
interests include: Cellular/molecular pharmacology; signal
transduction, hematopoietic growth factors, and cancer.
|